Literature DB >> 8168937

Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.

G A Jarvis1.   

Abstract

The deposition and degradation of human complement component C3 on the cell surfaces of Neisseria meningitidis and Neisseria gonorrhoeae were studied. Bacteria were incubated in human serum, and ester-linked C3 fragments were analyzed by hydroxylamine release and immunoblot detection. Similar patterns of C3 degradation were found for both serum-resistant and serum-sensitive meningococcal strains of serogroups A, B, C, Y, and W135, as well as for serum-sensitive gonococcal strains and their sialylated serum-resistant variants. The predominant fragments in all cases were the 40-kDa alpha' 2 chain of iC3b and the 75-kDa beta chain common to both C3b and iC3b. The 67-kDa alpha' 1 chain of iC3b was also detected. The 105-kDa alpha' chain of intact C3b represented a minor proportion of deposited C3. Capsule-specific immunoglobulin G or immunoglobulin A1 did not alter the observed degradation patterns, nor did incubation of meningococci in properdin-deficient serum. The degradation of C3 in C5-, C6-, or C8-deficient serum was the same as that in normal serum, although the deposition of C3 was severely limited, based as indicated by the intensity of the fragments. With the use of an enzyme-linked immunosorbent assay that measured total iC3b and C3, I found that both iC3b deposition and C3 deposition varied among meningococcal and gonococcal strains and that the amounts of iC3b and C3 were independent of the relative quantities of cell surface sialic acid and of serum sensitivity for meningococci but not for gonococci. I conclude that complement activation on neisserial cell surface results in the formation of an identical repertoire of predominantly iC3b fragments of ester-linked C3b molecules regardless of the presence of sialic acid in either the capsule or the lipooligosaccharide or of the sensitivity of the organism to complement-mediated lysis but that the quantities of both ester- and amide-linked iC3b molecules deposited exhibit strain variability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168937      PMCID: PMC186402          DOI: 10.1128/iai.62.5.1755-1760.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Disease due to serogroup W135 Neisseria meningitidis.

Authors:  J M Griffiss; B L Brandt
Journal:  Pediatrics       Date:  1979-08       Impact factor: 7.124

2.  Immunoenzymatic analysis by monoclonal antibodies of bacterial lipopolysaccharides after transfer to nitrocellulose.

Authors:  H Sidberry; B Kaufman; D C Wright; J Sadoff
Journal:  J Immunol Methods       Date:  1985-02-11       Impact factor: 2.303

3.  Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes.

Authors:  J J Kim; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  NEISSERIA GONORRHOEAE IDENTIFICATION IN DIRECT SMEARS BY A FLUORESCENT ANTIBODY-COUNTERSTAIN METHOD.

Authors:  L A WHITE; D S KELLOGG
Journal:  Appl Microbiol       Date:  1965-03

5.  Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.

Authors:  D E Isenman; D I Kells; N R Cooper; H J Müller-Eberhard; M K Pangburn
Journal:  Biochemistry       Date:  1981-07-21       Impact factor: 3.162

6.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.

Authors:  C A Nairn; J A Cole; P V Patel; N J Parsons; J E Fox; H Smith
Journal:  J Gen Microbiol       Date:  1988-12

7.  Comparative susceptibility of group B streptococci and Staphylococcus aureus to killing by oxygen metabolites.

Authors:  C B Wilson; W M Weaver
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

8.  Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae.

Authors:  K A Joiner; K A Warren; C Hammer; M M Frank
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

9.  In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.

Authors:  R E Mandrell; A J Lesse; J V Sugai; M Shero; J M Griffiss; J A Cole; N J Parsons; H Smith; S A Morse; M A Apicella
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.

Authors:  L F Fries; T A Gaither; C H Hammer; M M Frank
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  23 in total

1.  Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.

Authors:  M M Estabrook; J M Griffiss; G A Jarvis
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

2.  Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.

Authors:  U Vogel; A Weinberger; R Frank; A Müller; J Köhl; J P Atkinson; M Frosch
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils.

Authors:  M M Estabrook; D Zhou; M A Apicella
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 4.  Neisseria gonorrhoeae host adaptation and pathogenesis.

Authors:  Sarah Jane Quillin; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2018-02-12       Impact factor: 60.633

5.  Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Authors:  Sanjay Ram; Jutamas Shaughnessy; Rosane B de Oliveira; Lisa A Lewis; Sunita Gulati; Peter A Rice
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

Review 6.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Defining targets for complement components C4b and C3b on the pathogenic neisseriae.

Authors:  Lisa A Lewis; Sanjay Ram; Alpana Prasad; Sunita Gulati; Silke Getzlaff; Anna M Blom; Ulrich Vogel; Peter A Rice
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

10.  Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides.

Authors:  Sarika Agarwal; Shreekant Vasudhev; Rosane B DeOliveira; Sanjay Ram
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.